Viresolve Pro |
xMuLV |
≥3.72 |
(Gefroh,
Dehghani et al. 2014) |
|
|
≥4.8 |
(Miesegaes, Lute et al.
2010) |
|
|
≥4.43 - ≥5.89 |
(Stuckey, Strauss et
al. 2014) |
|
Reo-3 |
≥5.21 |
(Gefroh, Dehghani et al.
2014) |
|
|
≥4.78 - ≥6.63 |
(Stuckey, Strauss et
al. 2014) |
|
PRV |
≥3.56 |
(Gefroh, Dehghani et al.
2014) |
|
|
≥4.10 - ≥5.52 |
(Stuckey, Strauss et
al. 2014) |
Viresolve NFP |
xMuLV |
≥3.99 |
(Gefroh,
Dehghani et al. 2014) |
|
Reo-3 |
≥4.62 |
|
|
PRV |
≥4.23 |
|
Virosart CPV |
Reo-3 |
≥4.96 - ≥6.87 |
(Stuckey, Strauss et al.
2014) |
|
MuLV |
≥4.30 - ≥5.39 |
(Stuckey, Strauss
et al. 2014) |
|
|
>6.9 |
(Miesegaes, Lute
et al. 2010) |
|
PRV |
≥2.52 - ≥2.72 |
(Stuckey, Strauss
et al. 2014) |
Planova 20N |
xMuLV |
≥4.67 – ≥6.93 (single spike) |
(Stuckey, Strauss et al.
2014) |
|
|
≥4.65 – ≥7.45 (co-spike with PPV) |
|
|
|
Approx. ≥3.9 – ≥7.0 |
(Gefroh,
Dehghani et al. 2014) |
|
|
>5.2 |
(Miesegaes, Lute
et al. 2010) |
Pall DV20 |
xMuLV |
>5.3 |
(Miesegaes, Lute et al.
2010) |
Pall DV50 |
xMuLV |
>5.6 |
(Miesegaes, Lute et al.
2010) |
Various nominal pore size 15-20 nm filters (Planova 20N, Planova BioEX,
Viresolve Pro, Viresolve NFP, Ultipor DV20, Pegasus SV4, Pegasus Prime,
Virosart CPV, Virosart HF, Virosart HC) |
Approx. 25-40 nm (such as HAV,
BEV, EMCV, PEV, HPV-1, TMEV; FCV, SV40) |
Approx. ≥ 0.8 - ≥ 7.5 (some
cases viruses were detected in the filtrate. For those runs, LRVs were
2.0 – 6.9) |
(Roth, Dichtelmüller et al.
2020) |
|
Approx. 50-70 nm (such as BVDV, WNV; SINV, SFV) |
Approx. ≥ 3.0 - ≥
8.5 |
|
|
Approx. 70-120 nm (such as Reo3; HIV; VSV) |
Approx. ≥ 3.6 - ≥ 8.0 |
|
|
>120 nm (such as PRV, HSV-1, IBRV) |
Approx. ≥ 4.0 - ≥
8.5 |
|
Various small virus retentive filters (not specified) |
MuLV |
>99% of the cases, no detectable virus in the filtrate.
Majority of the cases, LRV >4. |
(Stuckey, Strauss et al.
2014) |
|
Reo-3 |
>99% of the cases, no detectable virus in the
filtrate. Majority of the cases, LRV >4. |
|
|
PRV |
>98% of the cases, no detectable virus in the
filtrate. Majority of the cases, LRV >4. |
|